October 24, 2012
Asahi Kasei Corp.
ZOLL Medical Corporation (ZOLL), a wholly owned US subsidiary of Asahi Kasei with operations in the field of critical care devices and systems, has established Asahi Kasei ZOLL Medical Corporation as its Japanese subsidiary. Starting operation on November 5, 2012, Asahi Kasei ZOLL Medical will advance the expansion and development of ZOLL’s business in Japan.
Asahi Kasei is targeting growth in the field of critical care, and in April 2012 acquired full ownership of ZOLL, a leading US manufacturer of critical care devices and systems. As a member company of the Asahi Kasei Group, ZOLL is accelerating the expansion of operations beyond the US and Europe, with a focus on Japan and other major Asian markets.
The ZOLL AED Plus™ automated external defibrillator has been marketed in Japan since August 2011 through Asahi Kasei subsidiary Admis, Inc. To further expand its Japanese business, ZOLL is working to obtain regulatory approval as quickly as possible for products currently sold in the US and Europe, while reinforcing its sales infrastructure in the country. Asahi Kasei ZOLL Medical will leverage the resources of the Asahi Kasei Group to facilitate these developments for the swift expansion of ZOLL’s business in Japan.
In close collaboration with Admis, Asahi Kasei ZOLL Medical will work to increase sales of the ZOLL AED Plus™ while advancing preparations for the sale of other approved products such as Thermogard™ temperature management systems and ZOLL AED Pro™ automated external defibrillators for use by professional rescuers. Application has been filed for Japanese regulatory approval of X Series™ monitor defibrillators1 and the LifeVest™ wearable defibrillator2, and preparations for sale will be swiftly advanced upon approval.
Corporate profile of Asahi Kasei ZOLL Medical Corporation
| President: | Seiji Sakano | |
|---|---|---|
| Location: | Tokyo, Japan | |
| Operation: | Sale of ZOLL critical care devices and systems in Japan | |
| Establishment: | August 8, 2012 | |
| Paid-in capital: | ¥10 million | |
| Shareholder: | ZOLL Medical Corporation (100%) |
Adobe Readeris required to view these PDF files.